Asian Pacific Association for the Study of the Liver (APASL) Conference on HCV 2017

Asian Pacific Association for the Study of the Liver Conference on HCV is organized by Asian Pacific Associaton for the Study of the Liver (APASL) and would be held during Sep 06 - 08, 2017 at Royal Maxim Palace Kempinski Cairo, Cairo, Egypt. This cme conference has been approved with maximum of 15 Europran CME credits.

The EACCME is an institution of the European Union of Medical Specialists (UEMS),Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credits.

After the two successful liver fibrosis STC meetings in Cairo on 2008 and 2014, the coming congress have been selected to focus on HCV and its remarkable fast progress in the new treatment modalities. Egyptians have the highest world prevalence of HCV of 14.7%. Luckily, we have the first world national program treating all our patients. It will be a good opportunity to discuss with the world experts in this field the results of their researches, and the real life results of different national protocols that are currently ongoing specially in the AsiaPacific region. By reaching the date of the congress on September 2017, there will be more than one million Egyptian patients that have been cured from the virus using the currently available DAAs.

The congress will provide an excellent opportunity to share and exchange experiences especially from the view of Asian Pacific countries regarding the latest scientific and evidence-based research results and recommendations to follow-up the cured patients, to treat their damaged liver cells, to dissolve their fibrous bands, to detect and treat early any rising liver cancers. These elements are essential to pave a way for better treatment of HCV patients not only in the AsiaPacific region but around the world.